These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 11668508

  • 1. Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
    Xu Z, Friess H, Solioz M, Aebi S, Korc M, Kleeff J, Büchler MW.
    Int J Cancer; 2001 Oct 15; 94(2):268-74. PubMed ID: 11668508
    [Abstract] [Full Text] [Related]

  • 2. Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment.
    Hopkins-Donaldson S, Cathomas R, Simões-Wüst AP, Kurtz S, Belyanskaya L, Stahel RA, Zangemeister-Wittke U.
    Int J Cancer; 2003 Aug 20; 106(2):160-6. PubMed ID: 12800189
    [Abstract] [Full Text] [Related]

  • 3. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X, Liu S, Kleeff J, Friess H, Büchler MW.
    Oncology; 2002 Aug 20; 62(4):354-62. PubMed ID: 12138244
    [Abstract] [Full Text] [Related]

  • 4. Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content.
    Bold RJ, Chandra J, McConkey DJ.
    Ann Surg Oncol; 1999 Aug 20; 6(3):279-85. PubMed ID: 10340887
    [Abstract] [Full Text] [Related]

  • 5. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
    Wang M, Lu X, Dong X, Hao F, Liu Z, Ni G, Chen D.
    World J Surg Oncol; 2015 Feb 21; 13():66. PubMed ID: 25880226
    [Abstract] [Full Text] [Related]

  • 6. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.
    Ou YQ, Zhu Wb, Li Y, Qiu PX, Huang YJ, Xie J, He SM, Zheng XK, Leng TD, Xu D, Yan GM.
    Acta Pharmacol Sin; 2010 Jan 21; 31(1):73-80. PubMed ID: 19966835
    [Abstract] [Full Text] [Related]

  • 7. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.
    Wei SH, Dong K, Lin F, Wang X, Li B, Shen JJ, Zhang Q, Wang R, Zhang HZ.
    Cancer Chemother Pharmacol; 2008 Nov 21; 62(6):1055-64. PubMed ID: 18297287
    [Abstract] [Full Text] [Related]

  • 8. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.
    Zhou Y, Liu H, Xue R, Tang W, Zhang S.
    Dig Dis Sci; 2018 Dec 21; 63(12):3367-3375. PubMed ID: 30155839
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents.
    Xu ZW, Friess H, Büchler MW, Solioz M.
    Cancer Chemother Pharmacol; 2002 Jun 21; 49(6):504-10. PubMed ID: 12107556
    [Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 1997 Jul 16; 89(14):1027-36. PubMed ID: 9230884
    [Abstract] [Full Text] [Related]

  • 11. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H, Sen S, Lo Muzio L, Mariggiò A, Singh N.
    Cancer Biol Ther; 2005 Jul 16; 4(7):720-7. PubMed ID: 15917659
    [Abstract] [Full Text] [Related]

  • 12. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
    Park JK, Lee EJ, Esau C, Schmittgen TD.
    Pancreas; 2009 Oct 16; 38(7):e190-9. PubMed ID: 19730150
    [Abstract] [Full Text] [Related]

  • 13. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
    Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, Ungefroren H.
    Int J Cancer; 2004 Mar 20; 109(2):182-8. PubMed ID: 14750167
    [Abstract] [Full Text] [Related]

  • 14. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
    Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R.
    Surgery; 2006 Aug 20; 140(2):149-60. PubMed ID: 16904964
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide.
    Fryer RA, Barlett B, Galustian C, Dalgleish AG.
    Anticancer Res; 2011 Nov 20; 31(11):3747-56. PubMed ID: 22110196
    [Abstract] [Full Text] [Related]

  • 16. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H, Wei W, Guo Y, Liu A, Tong H, Wang Z, Tan W, Liu J, Lin S.
    Oncol Rep; 2011 May 20; 25(5):1253-61. PubMed ID: 21305255
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
    Ibrahim SM, Ringel J, Schmidt C, Ringel B, Müller P, Koczan D, Thiesen HJ, Löhr M.
    Pancreas; 2001 Jul 20; 23(1):72-9. PubMed ID: 11451151
    [Abstract] [Full Text] [Related]

  • 18. Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer.
    Ge J, Ge C.
    Virchows Arch; 2019 Jan 20; 474(1):59-69. PubMed ID: 30267303
    [Abstract] [Full Text] [Related]

  • 19. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O, Tschopp S, Olie RA, Leech SH, Simões-Wüst AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 2001 Mar 21; 93(6):463-71. PubMed ID: 11259472
    [Abstract] [Full Text] [Related]

  • 20. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine].
    Zhang J, Jiang H, Mao Z, Wang X, Fan X, Liu Y, Wang Y.
    Zhonghua Zhong Liu Za Zhi; 2014 May 21; 36(5):335-40. PubMed ID: 25030587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.